Overview of Asia Pacific Life Sciences Real Estate
Asia Pacific is home to approximately 60% of the global population. The region includes the many of the world’s most populous and fastest-growing countries as well as several rapidly ageing societies.
Supported by expanding demand from a large and ageing population and a steady flow of M&A activity, recent years have seen the life sciences industry experience rapid growth in Asia Pacific.
While global pharmaceutical giants from the U.S. and Europe still dominate the market, homegrown firms are expanding rapidly. Recent years have also seen the emergence of Asia Pacific life science clusters possessing the talent, infrastructure, facilities, manufacturing capacity and other critical environments to meet the industry’s highly specialised requirements.
This report by CBRE Research provides an overview of Asia Pacific life sciences real estate, focusing on the key trends, demand drivers, corporate real estate strategies and investment opportunities in the region’s major life sciences hubs.